Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Revenue

Lexaria Bioscience had revenue of $84.00K in the quarter ending May 31, 2024, with 8.10% growth. This brings the company's revenue in the last twelve months to $411.02K, up 34.05% year-over-year. In the fiscal year ending August 31, 2023, Lexaria Bioscience had annual revenue of $226.21K, down -11.43%.

• Revenue (ttm): $411.02K
• Revenue Growth: +34.05%
• P/S Ratio: 55.86
• Revenue / Employee: $82,204
• Employees: 5
• Market Cap: 40.49M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2023	226.21K	-29.19K	-11.43%
Aug 31, 2022	255.40K	-467.34K	-64.66%
Aug 31, 2021	722.74K	407.95K	129.59%
Aug 31, 2020	314.79K	92.18K	41.41%
Aug 31, 2019	222.61K	-210.68K	-48.62%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.